BACKGROUND: Sleep-disordered breathing (SDB) may impact the course of medical illness among hospitalized patients. Access to testing during hospitalization to assess this may be limited by wait times for laboratory polysomnography. Level 3 portable monitoring (PM) may provide an alternative. OBJECTIVE: To assess the rate of technically adequate studies, diagnostic information obtained and impact on patient management of inpatient PM studies performed for SDB. METHODS: A retrospective review of 114 PM (Embletta, Natus Inc, Canada) records from the past two years was performed. Studies were ordered by pulmonologists, initiated by respiratory therapists and performed unattended on inpatient units. Admitting diagnoses, indication for sleep study, diagnostic information obtained from recordings and change in clinical management subsequent to PM were determined from medical charts. RESULTS: Of 114 studies reviewed, 99 (87%) met predetermined criteria for adequate signal quality and duration. Five studies could not be interpreted due to inadequate data, yielding an overall success rate of 83% (94 of 114). Of 86 studies performed for diagnosis, clinical and PM data supported a new diagnosis of SDB in 55 patients, of which 23 (42%) were started on positive pressure therapy. Thirteen PM studies were performed during SDB treatment. All were technically adequate and six of 13 demonstrated new or persistent SDB. Results from PM testing informed clinical management during hospitalization in 70 (61%) cases. CONCLUSION: Unattended level 3 PM studies are technically feasible in hospitalized patients and may provide information that influences clinical management.
BACKGROUND:Sleep-disordered breathing (SDB) may impact the course of medical illness among hospitalized patients. Access to testing during hospitalization to assess this may be limited by wait times for laboratory polysomnography. Level 3 portable monitoring (PM) may provide an alternative. OBJECTIVE: To assess the rate of technically adequate studies, diagnostic information obtained and impact on patient management of inpatient PM studies performed for SDB. METHODS: A retrospective review of 114 PM (Embletta, Natus Inc, Canada) records from the past two years was performed. Studies were ordered by pulmonologists, initiated by respiratory therapists and performed unattended on inpatient units. Admitting diagnoses, indication for sleep study, diagnostic information obtained from recordings and change in clinical management subsequent to PM were determined from medical charts. RESULTS: Of 114 studies reviewed, 99 (87%) met predetermined criteria for adequate signal quality and duration. Five studies could not be interpreted due to inadequate data, yielding an overall success rate of 83% (94 of 114). Of 86 studies performed for diagnosis, clinical and PM data supported a new diagnosis of SDB in 55 patients, of which 23 (42%) were started on positive pressure therapy. Thirteen PM studies were performed during SDB treatment. All were technically adequate and six of 13 demonstrated new or persistent SDB. Results from PM testing informed clinical management during hospitalization in 70 (61%) cases. CONCLUSION: Unattended level 3 PM studies are technically feasible in hospitalized patients and may provide information that influences clinical management.
Authors: John Fleetham; Najib Ayas; Doug Bradley; Kathy Ferguson; Michael Fitzpatrick; Charlie George; Patrick Hanly; Fran Hill; John Kimoff; Meir Kryger; Debra Morrison; Frederic Series; Willis Tsai Journal: Can Respir J Date: 2006-10 Impact factor: 2.409
Authors: Virend K Somers; David P White; Raouf Amin; William T Abraham; Fernando Costa; Antonio Culebras; Stephen Daniels; John S Floras; Carl E Hunt; Lyle J Olson; Thomas G Pickering; Richard Russell; Mary Woo; Terry Young Journal: Circulation Date: 2008-08-25 Impact factor: 29.690
Authors: Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley Journal: J Am Coll Cardiol Date: 2007-04-02 Impact factor: 24.094
Authors: Robert J Farney; James M Walker; Tom V Cloward; Kevin C Shilling; Kathleen M Boyle; Rustin G Simons Journal: J Clin Sleep Med Date: 2006-01-15 Impact factor: 4.062
Authors: Nancy A Collop; W McDowell Anderson; Brian Boehlecke; David Claman; Rochelle Goldberg; Daniel J Gottlieb; David Hudgel; Michael Sateia; Richard Schwab Journal: J Clin Sleep Med Date: 2007-12-15 Impact factor: 4.062
Authors: Priti Gros; Victoria P Mery; Anne-Louise Lafontaine; Ann Robinson; Andrea Benedetti; R John Kimoff; Marta Kaminska Journal: Parkinsons Dis Date: 2015-10-13